| abstract |
The present invention relates to complement activity modulators represented by formulas (1), (2) and (3) and containing at least one of a saponin or a saponenin compound having anti-complement activity, in particular, a disease therapeutic agent associated with complement activity.n n n Saponins or sapongenin compounds of the present invention are ginsenosides Ra 1 , ginsenosides Ra 2 , ginsenosides Rb 1 , ginsenosides Rb 2 , ginsenosides Rc, ginsenosides Rd, ginsenosides Re, ginsenosides Side Rf, ginsenoside Rg 1 , ginsenoside Rg 2 , ginsenoside Rh 1 , ginsenoside Rh 2 , ginsenoside Rh 4 , ginsenoside Ro, and oleanolic acid. |